BRPI0821139A2 - Derivados de esteróides agindo como agonistas de receptor de glicocorticosteróides - Google Patents
Derivados de esteróides agindo como agonistas de receptor de glicocorticosteróidesInfo
- Publication number
- BRPI0821139A2 BRPI0821139A2 BRPI0821139-6A BRPI0821139A BRPI0821139A2 BR PI0821139 A2 BRPI0821139 A2 BR PI0821139A2 BR PI0821139 A BRPI0821139 A BR PI0821139A BR PI0821139 A2 BRPI0821139 A2 BR PI0821139A2
- Authority
- BR
- Brazil
- Prior art keywords
- receptor agonists
- steroid derivatives
- derivatives acting
- glucocorticosteroid receptor
- glucocorticosteroid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1540407P | 2007-12-20 | 2007-12-20 | |
PCT/SE2008/051489 WO2009082342A1 (en) | 2007-12-20 | 2008-12-18 | Steroid derivatives acting as glucocorticosteroid receptor agonists |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0821139A2 true BRPI0821139A2 (pt) | 2015-06-16 |
Family
ID=40801455
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0821139-6A BRPI0821139A2 (pt) | 2007-12-20 | 2008-12-18 | Derivados de esteróides agindo como agonistas de receptor de glicocorticosteróides |
Country Status (10)
Country | Link |
---|---|
US (1) | US20110160167A1 (pt) |
EP (1) | EP2235037A1 (pt) |
JP (1) | JP2011507836A (pt) |
KR (1) | KR20100102121A (pt) |
CN (1) | CN101945885A (pt) |
AU (1) | AU2008341590A1 (pt) |
BR (1) | BRPI0821139A2 (pt) |
CA (1) | CA2707618A1 (pt) |
RU (1) | RU2010124799A (pt) |
WO (1) | WO2009082342A1 (pt) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ584160A (en) | 2007-10-04 | 2011-05-27 | Astrazeneca Ab | Steroidal [3,2-c] pyrazole compounds, with glucocorticoid activity |
UY32520A (es) | 2009-04-03 | 2010-10-29 | Astrazeneca Ab | Compuestos que tienen actividad agonista del receptor de glucocorticoesteroides |
EP3407916B1 (en) | 2016-01-29 | 2023-12-20 | Merck Sharp & Dohme LLC | Phosphonate linkers and their use to facilitate cellular retention of compounds |
KR102497070B1 (ko) * | 2016-10-14 | 2023-02-06 | 반 안델 리서치 인스티튜트 | 고효능 글루코코르티코이드의 설계를 위한 구조 및 메커니즘 |
CN110105420A (zh) * | 2019-06-04 | 2019-08-09 | 博诺康源(北京)药业科技有限公司 | 一种布地奈德杂质ep-zg的合成方法 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3129218A (en) * | 1961-11-01 | 1964-04-14 | Merck & Co Inc | 2-alkoxymethylene steroids of the androstane and pregnane series |
US3072639A (en) * | 1962-03-05 | 1963-01-08 | Merck & Co Inc | 16-oxygenated-4-pregneno-[3, 2-c] pyrazoles and process of preparing them |
US3364203A (en) * | 1965-09-09 | 1968-01-16 | Syntex Corp | 6, 7-methylene and 6, 7-halomethylene pyrazole pregnanes and processes for their preparation |
US3471477A (en) * | 1967-10-18 | 1969-10-07 | Syntex Corp | 6-gem-difluoro (3,2-c) and (2,3-d) pyrazole steroids |
DE2735110A1 (de) * | 1977-08-04 | 1979-02-15 | Hoechst Ag | Corticoid-17-alkylcarbonate und verfahren zu ihrer herstellung |
DE2817988A1 (de) * | 1978-04-25 | 1979-11-08 | Hoechst Ag | Corticoid 17-alkylcarbonate und verfahren zu deren herstellung |
SE8306370D0 (sv) * | 1983-11-18 | 1983-11-18 | Draco Ab | Novel androstane-17beta-carboxylic acid esters, a process and intermediates for their preparation, compositions and method for the treatment of inflammatory conditions |
DE3540537A1 (de) * | 1985-11-15 | 1987-05-21 | Klaus Kurt Koelzer | Verstaerkungsmaterial |
WO2005063777A1 (en) * | 2003-12-23 | 2005-07-14 | Corus Pharma | Benzylphosphate and substituted benzylphosphate prodrugs for the treatment of pulmonary inflammation |
NZ584160A (en) * | 2007-10-04 | 2011-05-27 | Astrazeneca Ab | Steroidal [3,2-c] pyrazole compounds, with glucocorticoid activity |
UY32525A (es) * | 2009-04-03 | 2010-10-29 | Astrazeneca Ab | Compuestos que tienen actividad agonista del receptor de glucocorticosteroides |
UY32520A (es) * | 2009-04-03 | 2010-10-29 | Astrazeneca Ab | Compuestos que tienen actividad agonista del receptor de glucocorticoesteroides |
UY32521A (es) * | 2009-04-03 | 2010-10-29 | Astrazeneca Ab | Combinación para emplear en el tratamiento de enfermedades respiratorias |
UY32523A (es) * | 2009-04-03 | 2010-10-29 | Astrazeneca Ab | Compuestos que tienen actividad agonista del receptor de glucocorticosteroides |
-
2008
- 2008-12-18 WO PCT/SE2008/051489 patent/WO2009082342A1/en active Application Filing
- 2008-12-18 JP JP2010539381A patent/JP2011507836A/ja active Pending
- 2008-12-18 BR BRPI0821139-6A patent/BRPI0821139A2/pt not_active IP Right Cessation
- 2008-12-18 CN CN2008801268528A patent/CN101945885A/zh active Pending
- 2008-12-18 CA CA2707618A patent/CA2707618A1/en not_active Abandoned
- 2008-12-18 EP EP08863416A patent/EP2235037A1/en not_active Withdrawn
- 2008-12-18 KR KR1020107013463A patent/KR20100102121A/ko not_active Application Discontinuation
- 2008-12-18 RU RU2010124799/04A patent/RU2010124799A/ru unknown
- 2008-12-18 AU AU2008341590A patent/AU2008341590A1/en not_active Abandoned
- 2008-12-18 US US12/809,131 patent/US20110160167A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
KR20100102121A (ko) | 2010-09-20 |
WO2009082342A1 (en) | 2009-07-02 |
JP2011507836A (ja) | 2011-03-10 |
US20110160167A1 (en) | 2011-06-30 |
AU2008341590A1 (en) | 2009-07-02 |
CN101945885A (zh) | 2011-01-12 |
CA2707618A1 (en) | 2009-07-02 |
RU2010124799A (ru) | 2012-01-27 |
EP2235037A1 (en) | 2010-10-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0820447A2 (pt) | Agonistas do receptor de glicocorticóides | |
ATE524460T1 (de) | Pyridon-gpr119-g-protein-gekoppelte rezeptoragonisten | |
BRPI0817562A2 (pt) | derivados de n-hidroxilsulfonamida como novos doadores de niltroxil fisiologicamente úteis | |
BRPI0911563A2 (pt) | uso de antagonista da progesterona | |
BR112012000107A2 (pt) | receptores de células t. | |
BRPI0716936A2 (pt) | derivados de adenosina como antigonistas de receptor de a2a | |
BRPI0817245A2 (pt) | Derivados e quinolina como antagonistas receptores de 5ht5a | |
BRPI0810613A2 (pt) | derivados de tetra-hidrocarbazol como ligantes de receptores acoplados à proteína g | |
DK2401269T3 (da) | Indolderivater som crth2-receptorantagonister | |
BRPI0813707A2 (pt) | Derivados de pirimidinil-piridazinona | |
DK2081951T3 (da) | Progesteron-receptorantagonister | |
BRPI0809992A2 (pt) | Derivados de pirrolopirimidina | |
BRPI0820113A2 (pt) | Derivados de isoxazolo-piridazina | |
BRPI0810462A2 (pt) | Derivados de quinolina-carboxamida como antagonistas de p2y12 | |
BRPI0821141A2 (pt) | Derivados de heteroarila como antagonistas do receptor de orexina | |
BRPI0906436A2 (pt) | Derivados de ftalazinona | |
BRPI0909157A2 (pt) | compostos heterocíclicos como antagonistas de receptores de adenosina | |
BRPI0812155A2 (pt) | derivados de espiroindolinona | |
BRPI0812518A2 (pt) | Derivados de indazolamida | |
BRPI0814236A2 (pt) | Derivados de quinazolinamida | |
BRPI0820649A2 (pt) | Derivados de isoxazalo-pirazina | |
BRPI0717937A2 (pt) | Compostos de pirazona como antagonistas do receptor mineralocorticóide | |
BRPI0717023A2 (pt) | Tiazol pirazolopirimidina como antagonistas do receptor de crf1 | |
BRPI0817061A2 (pt) | Derivados de pirrolidinilalquilisoquinolinona e -isoindolinona como antagonistas de histamina-3 | |
BRPI0720078A2 (pt) | 2-aminoquinolinas como antagonistas de receptores de 5-ht(5a) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |